Study Name:
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-2)
Targeted Disease(s):
Asthma
Purpose of Study:
The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma that is uncontrolled by inhaled corticosteroids (ICS) and conventional asthma controllers.
Study Dates:
January 20, 2026 - January 1, 2029
Type of Study:
Pre-Market
Study Design:
Controlled Design
Study Location:
Nationwide
Lead Institution:
Generate:Biomedicines
Funding Source:
Generate:Biomedicines
Sponsors:
Generate:Biomedicines
Contact:
Generate Recruitment
Contact Phone: 888-469-0033
Contact Email: [email protected]
ClinicalTrails.gov Identifier:
NCT07359846
